Overview

Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The use of topical retinoids is a mainstay and basis of early acne treatment to prevent the progression to inflammatory lesions. Post oral isotretinoin, it is not uncommon for non-inflammatory papules and comedones to recur. However, there has been no formal study to look at the prevention of recurrence of these acne lesions post isotretinoin in a long term basis. This may enhance the therapeutic options for post isotretinoin patients in order to prevent recurrence of their disease. Hypothesis Tretinoin microsphere 0.04% will prevent recurrence of acne lesions.
Phase:
Phase 4
Details
Lead Sponsor:
Dermatrials Research
Collaborator:
Johnson & Johnson
Treatments:
Isotretinoin
Tretinoin